I found the following video very informative regar
Post# of 72439
(Total Views: 863)
Posted On: 10/26/2020 2:43:47 PM
I found the following video very informative regarding the use of a Preprint Server as part of the Peer Review Paper process. Remember that a Peer Review Paper consists of scientific information written for a target audience of other scientists and the overall medical community. A Preprint is a method to get critical information out to the masses in an expeditious manner which is especially relevant in regards to a pandemic treatment.
Preprint information is an outstanding way to get scientific knowledge spread worldwide instantly but it needs to be carefully managed to protect the asset (Brilacidin) which will be described in great detail including mechanisms of action and formulation information. Much of this information can also be found on the IPIX website but has patent protection disclaimers posted throughout the website. The worldwide scientific community will be exposed to Brilacidin via the Preprint and IMO it will spawn numerous ideas of usage for treating CV19 as well as other areas of need resulting in multiple opportunities for IPIX. The worldwide scientific community which includes Big Pharma will be anxiously awaiting human trials that will validate the incredible results completed in lab testing.
My guess is that we could see the announcement of the Preprint any day between now and mid-November and it could very well happen independently within days of an FDA approval for the IND regarding Brilacidin as a COVID-19 treatment (B-CV19) which will in turn give a green light to human trials for B-CV19. This is an exciting time to be an IPIX investor.
https://www.youtube.com/watch?v=WGN1Rg765AM
Preprint information is an outstanding way to get scientific knowledge spread worldwide instantly but it needs to be carefully managed to protect the asset (Brilacidin) which will be described in great detail including mechanisms of action and formulation information. Much of this information can also be found on the IPIX website but has patent protection disclaimers posted throughout the website. The worldwide scientific community will be exposed to Brilacidin via the Preprint and IMO it will spawn numerous ideas of usage for treating CV19 as well as other areas of need resulting in multiple opportunities for IPIX. The worldwide scientific community which includes Big Pharma will be anxiously awaiting human trials that will validate the incredible results completed in lab testing.
My guess is that we could see the announcement of the Preprint any day between now and mid-November and it could very well happen independently within days of an FDA approval for the IND regarding Brilacidin as a COVID-19 treatment (B-CV19) which will in turn give a green light to human trials for B-CV19. This is an exciting time to be an IPIX investor.
https://www.youtube.com/watch?v=WGN1Rg765AM
(18)
(0)